Min Su Hyon

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial

Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn et al. · Clinical Therapeutics · 2018 · 62 citations · Full text

Serum Resistin as a Biological Marker for Coronary Artery Disease and Restenosis in Type 2 Diabetic Patients

Young Keun On, Hyeong Kyu Park, Min Su Hyon et al. · Circulation Journal · 2007 · 53 citations · Full text

Implication of Left Ventricular Diastolic Dysfunction in Cryptogenic Ischemic Stroke

Jae-Young Seo, Kyung Bok Lee, Jung-Gon Lee et al. · Stroke · 2014 · 32 citations